Literature DB >> 1625395

[Assessment of alveolar epithelial permeability in progressive systemic sclerosis (PSS) using 99mTc-DTPA (diethylene triamine penta acetate) aerosol inhalation].

A Nakano1, E Yamaguchi, S Naitoh, T Fukuda, N Takayanagi, A Hasegawa, T Suzuki, K Murata, M Shigeta.   

Abstract

To evaluate alveolar epithelial damage in PSS, we studied pulmonary epithelial permeability by measuring the clearance of inhaled 99mTc-DTPA aerosol and performing thin slice CT scan, pulmonary function tests and right heart catheterization in 28 patients with PSS. The 99mTc-DTPA clearance rate (kep value) in PSS was greater than in 11 non-smoking normal subjects (18.2 +/- 7.63 x 10(-3)/min vs. 9.12 +/- 0.77 x 10(-3)/min, p less than 0.01). In PSS, the kep value did not correlate with age, sex, duration of illness, dermal lesions, % vital capacity, or PaO2. In contrast, the kep value showed significant correlations with %DLco (diffusing capacity for carbon monoxide), extent of interstitial lesions evaluated by CT scan (CT score), and mean pulmonary artery pressure. On the other hand, the kep value was high in some patients with normal CT scan and normal %DLco. These findings indicate that pulmonary interstitial lesions in PSS are accompanied by alveolar epithelial damage, and that the clearance of 99mTc-DTPA may be an early predictor of interstitial change.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1625395

Source DB:  PubMed          Journal:  Nihon Kyobu Shikkan Gakkai Zasshi        ISSN: 0301-1542


  2 in total

1.  Pulmonary (99m)Tc-DTPA aerosol clearance and survival in usual interstitial pneumonia (UIP).

Authors:  N Mogulkoc; M H Brutsche; P W Bishop; B Murby; M S Greaves; A W Horrocks; M Wilson; C McCullough; M Prescott; J J Egan
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  Biomarkers of scleroderma lung disease: recent progress.

Authors:  Faye N Hant; Richard M Silver
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.